GB0130553D0 - 1,4-Dihydro-1,4-diphenylpyridine derivitives - Google Patents

1,4-Dihydro-1,4-diphenylpyridine derivitives

Info

Publication number
GB0130553D0
GB0130553D0 GBGB0130553.1A GB0130553A GB0130553D0 GB 0130553 D0 GB0130553 D0 GB 0130553D0 GB 0130553 A GB0130553 A GB 0130553A GB 0130553 D0 GB0130553 D0 GB 0130553D0
Authority
GB
United Kingdom
Prior art keywords
derivitives
diphenylpyridine
dihydro
diphenylpyridine derivitives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0130553.1A
Other versions
GB2383326A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to GB0130553A priority Critical patent/GB2383326A/en
Publication of GB0130553D0 publication Critical patent/GB0130553D0/en
Priority to PCT/EP2002/013931 priority patent/WO2003053930A1/en
Priority to CA002470813A priority patent/CA2470813A1/en
Priority to AU2002361992A priority patent/AU2002361992A1/en
Priority to EP02796589A priority patent/EP1458682B1/en
Priority to JP2003554646A priority patent/JP4486817B2/en
Priority to DE60214428T priority patent/DE60214428T2/en
Priority to US10/498,967 priority patent/US7199136B2/en
Priority to ES02796589T priority patent/ES2271365T3/en
Publication of GB2383326A publication Critical patent/GB2383326A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
GB0130553A 2001-12-20 2001-12-20 Antiinflammatory dihydropyridines Withdrawn GB2383326A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB0130553A GB2383326A (en) 2001-12-20 2001-12-20 Antiinflammatory dihydropyridines
ES02796589T ES2271365T3 (en) 2001-12-20 2002-12-09 DERIVATIVES OF 1,4-DIHIDRO-1,4-DIFENYLPIRIDINE.
EP02796589A EP1458682B1 (en) 2001-12-20 2002-12-09 1,4-dihydro-1,4-diphenylpyridine derivatives
CA002470813A CA2470813A1 (en) 2001-12-20 2002-12-09 1,4-dihydro-1,4-diphenylpyridine derivatives
AU2002361992A AU2002361992A1 (en) 2001-12-20 2002-12-09 1,4-dihydro-1,4-diphenylpyridine derivatives
PCT/EP2002/013931 WO2003053930A1 (en) 2001-12-20 2002-12-09 1,4-dihydro-1,4-diphenylpyridine derivatives
JP2003554646A JP4486817B2 (en) 2001-12-20 2002-12-09 1,4-dihydro-1,4-diphenylpyridine derivative
DE60214428T DE60214428T2 (en) 2001-12-20 2002-12-09 1, 4-DIHYDRO-1, 4-DIPHENYLPYRIDINE DERIVATIVES
US10/498,967 US7199136B2 (en) 2001-12-20 2002-12-09 1,4-dihydro-1,4-diphenylpyridine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0130553A GB2383326A (en) 2001-12-20 2001-12-20 Antiinflammatory dihydropyridines

Publications (2)

Publication Number Publication Date
GB0130553D0 true GB0130553D0 (en) 2002-02-06
GB2383326A GB2383326A (en) 2003-06-25

Family

ID=9928089

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0130553A Withdrawn GB2383326A (en) 2001-12-20 2001-12-20 Antiinflammatory dihydropyridines

Country Status (1)

Country Link
GB (1) GB2383326A (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2390849A (en) * 2002-07-17 2004-01-21 Bayer Ag 3-Acyl-1,4-dihydro-1,4-di(phenyl/azinyl/diazinyl)pyridine derivatives for use as human neutrophil elastase inhibitors
GB0219896D0 (en) 2002-08-27 2002-10-02 Bayer Ag Dihydropyridine derivatives
SE0302486D0 (en) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
SE0302487D0 (en) * 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
ATE516285T1 (en) * 2004-02-19 2011-07-15 Bayer Schering Pharma Ag DIHYDROPYRIDINONE DERIVATIVES
TW200808763A (en) 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds I
TW200808771A (en) 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds II
BRPI0819258A2 (en) 2007-11-06 2017-05-02 Astrazeneca Ab some 2-pyrazinone derivatives and their use as neutrophil elastase inhibitors
TW201036957A (en) 2009-02-20 2010-10-16 Astrazeneca Ab Novel salt 628
KR20120099639A (en) 2009-10-02 2012-09-11 아스트라제네카 아베 2-pyridone compounds used as inhibitors of neutrophil elastase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE257479T1 (en) * 1999-12-10 2004-01-15 Pfizer 5-RING HETEROARYL-SUBSTITUTED 1,4-DIHYDROPYRIDINES AS BRADYKININ ANTAGONISTS

Also Published As

Publication number Publication date
GB2383326A (en) 2003-06-25

Similar Documents

Publication Publication Date Title
IL160081A0 (en) Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
IL153508A0 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
TW595857U (en) 091219345
IL161881A (en) N,n'-substituted-1,3-diamino-2- hydroxypropane derivatives
IL157704A0 (en) 4,5-dihydro-1h-pyrazole derivatives having potent cbi-antagonistic activity
MXPA03007093A (en) New composition.
MXPA03009558A (en) Novel compounds.
HK1051193A1 (en) (1,4')-Bipiperidine compounds.
AU4787301A (en) 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds
MXPA03008216A (en) Phenyl derivatives 3.
MXPA03008139A (en) Substituted fluoroalcoxyphenylsulfonylurea.
GB0130553D0 (en) 1,4-Dihydro-1,4-diphenylpyridine derivitives
EG23378A (en) Composition.
IL162310A0 (en) 3,4-Dihydro-1h-isoquinoloin-2-yl-derivatives
MXPA01011743A (en) 5 substituted arylpyrimidines.
HK1066022A1 (en) Use of 1,1,1,3,3-pentafluorobutan
HK1059781A1 (en) New phenylpiperazines.
MXPA03007242A (en) $g(d)1.
MXPA03008441A (en) Dgr;1.
PT1497256E (en) Substituted 1,5-diaminopentan-3-ol compounds
IL159965A0 (en) Novel 2,4-diaminothiazole derivatives
HK1057551A1 (en) Substituted 3,4-dihydro-pyridoÄ1,2-AÜpyrimidines.
PL371851A1 (en) 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives
TW539396U (en) 090220607
GB0118917D0 (en) Biopower 3

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)